Division of Neonatology, The Hospital for Sick Children, Toronto, Canada.
Arch Dis Child Fetal Neonatal Ed. 2010 Sep;95(5):F345-51. doi: 10.1136/adc.2009.173724. Epub 2010 Jun 10.
Surfactant replacement therapy (SRT) reduces respiratory morbidity and mortality in premature infants. The goal of this study was to characterise the effects of delivery room SRT on the ductus arteriosus and early neonatal haemodynamics.
A prospective observational study was conducted in preterm infants of less than 32 weeks' gestation who received SRT within 30 min of birth. Serial echocardiography was performed before and after SRT. Characteristics of the ductus arteriosus, myocardial performance, right ventricular output (RVO) and left ventricular output (LVO) and the ratio of RVO:LVO were measured.
Sixteen babies, born at 28.3+/-1.3 weeks' gestation and weighing 1289+/-224 g, were studied. SRT was associated with an improvement in the arterial oxygen tension:fractional inspired oxygen ratio (p<0.001), increased systolic and decreased diastolic arterial pressure (p<0.05). The ductus arteriosus was patent in all and transductal flow was unrestrictive and exclusively left-to-right after SRT. An increase in transductal diameter (p<0.001), left atrium:aortic ratio (p=0.006) but a decrease in left ventricular end-diastolic dimension (p=0.02) was identified.
SRT administration was followed by increased RVO but decreased LVO, resulting in an increased RVO:LVO ratio and an increase in ductal size. Delivery room administration of SRT is associated with major haemodynamic changes. The impact of these changes needs prospective evaluation.
表面活性物质替代疗法(SRT)可降低早产儿的呼吸发病率和死亡率。本研究的目的是描述产房内 SRT 对动脉导管和新生儿早期血液动力学的影响。
对胎龄小于 32 周且在出生后 30 分钟内接受 SRT 的早产儿进行前瞻性观察性研究。在 SRT 前后进行连续超声心动图检查。测量动脉导管的特征、心肌功能、右心室输出(RVO)和左心室输出(LVO)以及 RVO:LVO 的比值。
研究了 16 名胎龄 28.3+/-1.3 周、体重 1289+/-224 g 的婴儿。SRT 与动脉血氧分压:吸入氧分数比的改善相关(p<0.001),收缩压升高,舒张压降低(p<0.05)。所有婴儿的动脉导管均开放,跨导管血流在 SRT 后均为不受限制的左向右分流。跨导管直径增加(p<0.001),左心房:主动脉比值增加(p=0.006),但左心室舒张末期直径减小(p=0.02)。
SRT 给药后 RVO 增加,但 LVO 减少,导致 RVO:LVO 比值增加,导管大小增加。产房内给予 SRT 会引起主要的血液动力学变化。这些变化的影响需要前瞻性评估。